Target intelligence / Profile preview

Damage induced long noncoding RNA (DINO)

Target
DINO
Molecular classification
Long noncoding RNA (lncRNA), Other (ncRNA regulatory molecule, not a protein)
01

Overview

Damage induced long noncoding RNA (DINO) is a conserved, noncoding RNA transcribed in response to cellular DNA damage, most strongly induced by agents such as doxorubicin, and regulated by p53. As a lncRNA, DINO does not encode a protein but instead binds physically to p53, promoting its stability, amplifying its signaling, and ensuring robust transcriptional activation of p53-dependent genes involved in cell cycle arrest and apoptosis. DINO provides an auto-amplification loop within the p53 network: DNA damage induces DINO, which in turn stabilizes and activates p53, further driving expression of stress response genes. Loss or silencing of DINO blunts p53 signaling, reduces cell cycle arrest and apoptosis in response to DNA damage, and in experimental models, protects against excessive p53-driven cell death such as in acute radiation syndrome. While DINO is not currently a direct drug target, it plays a crucial role in the integrity of the DNA damage response pathway and may influence the efficacy of p53-targeted cancer therapies

Other names
DINOLDINODamage Induced NoncodingDINO lncRNA
02

Mechanism of action

Not applicable; DINO function is indirect modulation of p53, not a conventional drug target. Drugs acting on p53 may be indirectly affected by DINO status, but DINO is not directly targeted

03

Biological functions

DNA damage response (DDR)Regulation of p53-dependent gene expressionCell cycle arrestApoptosisp53 protein stabilization
04

Disease associations

CancerRadiation syndromeOther
05

Safety considerations

None known for direct therapeutic intervention; challenges for any future therapies might include precise control of tumor suppressor pathways (risk: promoting cancer or excessive cell death)

Beyond the preview

Go deeper on Damage induced long noncoding RNA (DINO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damage induced long noncoding RNA (DINO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call